Keywords: Digoxin, Prostate cancer risk, Heart drug, Johns Hopkins

Heart drug digoxin cuts prostate cancer risk; holds potential for therapeutic use

Article | 05 April 2011

Johns Hopkins scientists and their colleagues paired laboratory and epidemiologic data to find that men using the cardiac drug, digoxin, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in